Opportunity Information: Apply for PAR 24 084
The NIH National Center for Complementary and Integrative Health (NCCIH) is offering an R34 grant opportunity (PAR-24-084) to fund feasibility clinical trials of complementary and integrative health approaches that use physical and/or psychological therapeutic inputs, often referred to as mind and body interventions. The focus is on conditions and topics that NCCIH has already identified as high-priority research areas. The central purpose is not to run a full-scale efficacy or effectiveness trial yet, but to generate the practical and scientific groundwork needed to design a strong, competitive, subsequent larger clinical trial that fits within NCCIHs mission and could ultimately have meaningful public health impact.
This NOFO is specifically aimed at feasibility trials that answer the kinds of questions that commonly make or break a later large trial. Applicants are expected to clearly describe the future clinical trial they intend to pursue after the R34, and to make a convincing case that the feasibility work proposed here is scientifically necessary for that next step. In other words, the R34 project should be built around closing specific knowledge gaps that currently prevent a well-justified, well-designed full-scale study. NCCIH is looking for applications where the feasibility aims are tightly linked to clear design decisions for the later trial, rather than general pilot work that is not clearly connected to a next-stage protocol.
Examples of the kinds of feasibility issues this opportunity is meant to support include determining whether an intervention is acceptable and workable when there is little or no prior published feasibility data, and tailoring or adapting an intervention so it fits a particular population, delivery modality, or real-world setting. It also includes refining the content and structure of the intervention, such as identifying an appropriate session frequency, intensity, or duration that participants can realistically follow. The NOFO highlights operational questions too, including whether recruitment strategies will succeed, whether retention is likely to be adequate, and whether data collection procedures are realistic and produce usable data. It also supports work to refine and test the feasibility of protocolized multi-component interventions (where multiple elements need to be delivered in a standardized way), and to examine whether proposed control conditions are acceptable and whether participants will adhere to them, since weak control adherence can undermine a later full-scale trial.
Because this is an R34 clinical trial mechanism, the funding is explicitly for clinical trial activity at the feasibility stage, with the expectation that the results will directly inform a subsequent clinical efficacy or effectiveness study, a pragmatic trial, or a dissemination and implementation trial. The later full-scale trial is expected to be designed in a way that could plausibly produce findings with significant public health relevance, not just small or narrowly applicable results. NCCIH also encourages applicants to contact the appropriate NCCIH scientific or research program staff before submitting, which can help ensure the proposed topic aligns with NCCIH priorities and that the feasibility aims are appropriate for this mechanism.
A required element of the application is a Plan for Enhancing Diverse Perspectives (PEDP), reflecting NIH and NCCIH emphasis on bringing a broader range of viewpoints and participation into the research enterprise. While the specific content of the PEDP will depend on the project, applicants should plan for how they will incorporate diverse perspectives in ways that strengthen the science and improve relevance to the populations affected by the targeted conditions.
Eligibility for this opportunity is broad and includes many types of domestic organizations such as state, county, and local governments; special districts; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other eligible entities. The NOFO also explicitly notes additional eligible applicant types such as faith-based and community-based organizations and a range of minority-serving institutions, including HBCUs, Hispanic-serving institutions, AANAPISISs, Tribal Colleges and Universities, and Alaska Native and Native Hawaiian Serving Institutions. Foreign organizations are not eligible to apply directly, and non-U.S. components of U.S. organizations are not eligible to apply, but foreign components (as defined by NIH policy) are allowed, meaning certain elements of the work can be conducted abroad under NIH rules if appropriately justified and structured.
Key administrative details include that this is a discretionary grant program within the health funding activity category (CFDA 93.213) administered by NIH, with an award ceiling listed as $450,000. The original closing date shown is 2026-11-13. Overall, the opportunity is best suited for teams that already have a credible concept for a later full-scale NCCIH-relevant clinical trial, but need targeted feasibility data to finalize the intervention approach, participant procedures, controls, and operational methods required to run that definitive study successfully.Apply for PAR 24 084
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
- This funding opportunity was created on 2023-12-20.
- Applicants must submit their applications by 2026-11-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $450,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: FY24 IIJA/IRA Bureau of Land Management Nevada (NV) Aquatic Resource Management
Previous opportunity: USAID/Ukraine - Request for Information (RFI): Private Sector Development in Ukraine
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 24 084
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 24 084) also looked into and applied for these:
| Funding Opportunity |
|---|
| Supporting Health Systems Strengthening in Haiti Apply for 72052124RFI00001 Funding Number: 72052124RFI00001 Agency: Haiti USAID-Port Au Prince Category: Health Funding Amount: Case Dependent |
| NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) Apply for PAR 24 101 Funding Number: PAR 24 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA HG 24 006 Funding Number: RFA HG 24 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed) Apply for PAR 24 105 Funding Number: PAR 24 105 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional) Apply for PAR 24 106 Funding Number: PAR 24 106 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult Services (U01 Clinical Trials Optional) Apply for RFA HG 24 001 Funding Number: RFA HG 24 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional) Apply for PAR 24 107 Funding Number: PAR 24 107 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA HG 24 013 Funding Number: RFA HG 24 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) Apply for PAR 24 096 Funding Number: PAR 24 096 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) Apply for PAR 24 095 Funding Number: PAR 24 095 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) Apply for PAR 24 097 Funding Number: PAR 24 097 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) Apply for PAR 24 098 Funding Number: PAR 24 098 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed) Apply for PAR 24 129 Funding Number: PAR 24 129 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed) Apply for PAR 24 112 Funding Number: PAR 24 112 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed) Apply for PAR 24 111 Funding Number: PAR 24 111 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Evaluation and Coordinating Center for the AHRQ/PCORI Learning Health System Embedded Scientist Training and Research Centers (U18) Apply for RFA HS 24 002 Funding Number: RFA HS 24 002 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $1,000,000 |
| Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed) Apply for RFA AI 24 003 Funding Number: RFA AI 24 003 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| USAID/Kenya and East Africa Global Health Security (GHS) Activity Apply for 72061524RFI00002 Funding Number: 72061524RFI00002 Agency: Kenya USAID-Nairobi Category: Health Funding Amount: Case Dependent |
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) Apply for PAR 24 099 Funding Number: PAR 24 099 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 24 100 Funding Number: PAR 24 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 24 084", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
